According to research reviewed by Gram, a 2026 study found that vitamin A supplementation significantly increased new brain cell growth and activated memory-related brain chemicals in an Alzheimer’s disease rat model, with medium-dose vitamin A (3000 IU/kg/day) performing as well as standard Alzheimer’s medication. The treatment also reversed liver damage caused by the disease. However, these are early-stage animal findings—human clinical trials are needed before vitamin A becomes a standard Alzheimer’s treatment, and high-dose supplementation should only be pursued under medical supervision.
According to research reviewed by Gram, a new study suggests that vitamin A could help the brain repair itself in Alzheimer’s disease by activating special brain cells called astrocytes. Researchers found that Alzheimer’s depletes vitamin A in the brain and liver, but giving rats the right dose of vitamin A restored brain cell growth, improved memory-related brain chemicals, and even reversed liver damage. The study used a rat model of Alzheimer’s and tested different vitamin A doses, finding that a medium dose worked best. While these results are promising, the research is still in early stages and more human studies are needed before vitamin A supplements become a standard Alzheimer’s treatment.
Key Statistics
A 2026 study in Scientific Reports found that medium-dose vitamin A (3000 IU/kg/day) significantly enhanced new brain cell growth and activated key genes controlling brain cell development in rats with Alzheimer’s-like disease.
The same study demonstrated that vitamin A supplementation reversed liver fibrosis (scarring) induced by Alzheimer’s disease in rats, measured by decreased markers of liver damage and confirmed through tissue examination.
In the rat Alzheimer’s model, medium-dose vitamin A performed as well as or better than donepezil, the standard Alzheimer’s medication, at enhancing cholinergic neuron regeneration—brain cells critical for memory and learning.
The Quick Take
- What they studied: Whether vitamin A can help the brain grow new nerve cells and improve brain function in Alzheimer’s disease by activating special support cells in the brain.
- Who participated: Rats with an experimentally-induced Alzheimer’s-like condition received different doses of vitamin A or a standard Alzheimer’s medication for comparison.
- Key finding: Medium-dose vitamin A significantly increased the growth of new brain cells, activated brain-protective genes, improved memory-related brain chemicals, and reversed liver damage caused by Alzheimer’s.
- What it means for you: This research suggests vitamin A supplementation might help the brain repair itself in Alzheimer’s disease, but these are early-stage animal studies. Do not start taking high-dose vitamin A supplements based on this research alone—talk to your doctor first, as too much vitamin A can be harmful.
The Research Details
Researchers used rats with a chemically-induced form of Alzheimer’s disease to test whether vitamin A could help the brain heal itself. They traced where vitamin A goes in the brain and liver using special microscopy techniques, then gave different groups of rats either no treatment, standard Alzheimer’s medication (donepezil), or three different doses of vitamin A (1500, 3000, or 4500 IU per kilogram of body weight daily). The researchers measured multiple outcomes including new brain cell growth, activation of genes that control brain cell development, liver damage, and markers of Alzheimer’s disease like amyloid-beta and tau protein.
The study focused on how vitamin A works through special brain support cells called astrocytes. These cells normally help protect neurons, but in Alzheimer’s disease they become overactive and may lose their vitamin A stores. The researchers hypothesized that vitamin A depletion contributes to both brain damage and liver damage, and that restoring vitamin A could activate genes that promote new brain cell growth while also protecting the liver.
This is a mechanistic study designed to understand how vitamin A affects the brain at a molecular level. The researchers used advanced techniques to measure gene expression, protein activation, and tissue damage, providing detailed information about the biological pathways involved.
Understanding how vitamin A affects brain repair mechanisms is important because current Alzheimer’s treatments only temporarily slow symptoms—they don’t stop the disease or help the brain regenerate. If vitamin A can activate the brain’s natural repair systems, it could represent a fundamentally different approach to treatment. Additionally, the finding that Alzheimer’s causes liver damage and that vitamin A reverses this suggests the disease affects multiple organ systems in ways we didn’t fully understand before.
This study was published in Scientific Reports, a peer-reviewed journal. The research used multiple measurement techniques and examined several biological pathways, which strengthens the findings. However, this is an animal study in rats, not humans, so results may not directly translate to people. The study did not specify the exact number of rats used, which makes it harder to assess statistical power. The researchers used established animal models and standard measurement techniques, which supports reliability. The main limitation is that animal studies often don’t produce the same results in humans due to differences in metabolism and brain structure.
What the Results Show
Vitamin A supplementation, particularly at the medium dose (3000 IU/kg/day), significantly increased the growth of new brain cells in the Alzheimer’s rat model. This was measured by increased levels of DCX, a marker of newly formed neurons. The medium-dose vitamin A also activated key genes (NGN2 and SOX-11) that control how brain cells develop and specialize, and it increased SIRT-1, a protein that protects brain cells and controls gene activity.
The vitamin A treatment specifically enhanced the growth of cholinergic neurons—brain cells that produce acetylcholine, a chemical messenger critical for memory and learning. This is particularly important because Alzheimer’s disease damages these specific neurons, leading to memory loss. The medium-dose vitamin A performed as well as or better than donepezil, the standard Alzheimer’s medication used in the study.
Beyond the brain, vitamin A supplementation reversed liver fibrosis (scarring) that was induced by the Alzheimer’s condition. This was measured by decreased levels of TGF-beta and hydroxyproline, markers of liver damage, and confirmed by examining liver tissue under a microscope. The reversal of liver damage suggests that vitamin A has systemic protective effects beyond the brain.
The study found that Alzheimer’s disease caused vitamin A depletion in both the brain and liver, measured by decreased retinol-binding protein and ALDH1A1 expression. This depletion appeared to be a key mechanism linking brain damage to liver damage. Interestingly, the highest dose of vitamin A (4500 IU/kg/day) did not produce better results than the medium dose, suggesting there may be an optimal dose range. The study also found that vitamin A supplementation reduced amyloid-beta deposition and serum tau levels, two hallmark markers of Alzheimer’s disease pathology.
This research builds on earlier findings showing that vitamin A and its active form (retinoic acid) regulate brain cell development and protect against neurodegeneration. Previous studies have shown that astrocytes store vitamin A and that these cells play a role in brain repair. This study is novel in demonstrating that Alzheimer’s disease specifically depletes brain vitamin A stores and that restoring vitamin A can activate the brain’s natural regenerative pathways through specific genes and proteins. The finding that vitamin A affects both brain and liver health in Alzheimer’s disease is relatively new and suggests a more integrated view of how the disease affects the whole body.
This study used rats, not humans, so results may not directly apply to people with Alzheimer’s disease. The study did not report the exact number of animals used, making it difficult to assess whether the sample size was adequate. The Alzheimer’s model used (scopolamine-induced) creates some features of Alzheimer’s but not all—it’s a simplified version of the human disease. The study measured biological markers and brain cell growth but did not test whether vitamin A actually improved memory or cognitive function in the rats. The optimal vitamin A dose in humans may differ from the rat doses tested. This is a short-term study, so we don’t know if the benefits would persist over months or years. Finally, the study doesn’t address potential side effects or toxicity of long-term vitamin A supplementation at these doses.
The Bottom Line
Based on this animal research, vitamin A supplementation shows promise for Alzheimer’s disease, but human clinical trials are needed before making treatment recommendations. Current evidence is moderate-quality (animal study only). If you or a family member has Alzheimer’s disease, discuss vitamin A supplementation with your neurologist or doctor—do not self-treat with high-dose supplements. Standard vitamin A intake through diet (found in carrots, sweet potatoes, spinach, and liver) is safe and recommended. High-dose vitamin A supplements can be toxic and cause liver damage, headaches, and bone problems, so supplementation should only be done under medical supervision.
This research is most relevant to Alzheimer’s disease researchers, neurologists, and people with Alzheimer’s disease or family members seeking new treatment options. People interested in brain health and aging may find the mechanisms interesting. This research should NOT be used by people to self-treat with vitamin A supplements without medical guidance. People with liver disease, pregnant women, and those taking certain medications should be especially cautious about high-dose vitamin A.
In the rat study, benefits appeared within the treatment period, but the exact duration wasn’t specified. If vitamin A supplementation were to be tested in humans, it would likely take months to years to see measurable improvements in cognitive function. Any human clinical trial would need to follow patients for extended periods to determine if benefits persist and whether side effects emerge.
Frequently Asked Questions
Can vitamin A supplements help treat Alzheimer’s disease?
A 2026 rat study found vitamin A supplementation enhanced brain cell growth and activated memory-related genes, but human clinical trials are needed. Do not self-treat with high-dose vitamin A—it can be toxic. Discuss supplementation with your doctor before starting.
What dose of vitamin A was most effective in the study?
The medium dose (3000 IU/kg/day) produced the best results in rats, performing as well as standard Alzheimer’s medication. Higher doses didn’t improve outcomes. Human-equivalent doses would differ significantly and require medical determination.
Does Alzheimer’s disease affect vitamin A levels in the body?
Yes, the study found that Alzheimer’s disease depletes vitamin A in both the brain and liver, measured by decreased vitamin A-related proteins. This depletion may contribute to both brain and liver damage in the disease.
What are the risks of taking high-dose vitamin A supplements?
High-dose vitamin A can cause liver damage, headaches, bone pain, and birth defects in pregnancy. Toxicity risk increases with prolonged supplementation. This is why medical supervision is essential before starting vitamin A supplements.
How can I get more vitamin A naturally through food?
Excellent food sources include carrots, sweet potatoes, spinach, kale, liver, and eggs. These provide vitamin A safely without toxicity risk. Aim for colorful orange and dark green vegetables daily for natural vitamin A intake.
Want to Apply This Research?
- If your doctor approves vitamin A supplementation, track your weekly vitamin A intake (in IU), any cognitive changes you notice (memory, focus, clarity on a 1-10 scale), and any side effects (headaches, nausea, joint pain). Record this weekly in your health app.
- Work with your healthcare provider to determine an appropriate vitamin A dose if supplementation is recommended. Alternatively, increase dietary sources of vitamin A (orange and dark green vegetables, liver) and track consumption. Log weekly cognitive assessments and any changes in memory or mental clarity.
- Establish a baseline cognitive assessment with your doctor, then track monthly changes in memory, attention, and daily functioning. Monitor liver function through periodic blood tests if taking supplements. Keep a symptom journal noting any improvements or side effects. Share data with your healthcare provider every 3 months to adjust the approach if needed.
This research is from an animal study in rats and has not been tested in humans. Vitamin A supplementation should only be undertaken under medical supervision, as high-dose vitamin A can be toxic and cause serious side effects including liver damage. This article is for educational purposes and should not be used for self-diagnosis or self-treatment. If you or a loved one has Alzheimer’s disease or cognitive concerns, consult with a qualified neurologist or healthcare provider before making any changes to supplements or medications. Do not discontinue any current Alzheimer’s treatments based on this research.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.